ITRM
Price
$0.72
Change
-$0.02 (-2.70%)
Updated
Sep 26, 04:12 PM (EDT)
Capitalization
33.18M
42 days until earnings call
KOD
Price
$15.89
Change
+$0.21 (+1.34%)
Updated
Sep 26, 04:21 PM (EDT)
Capitalization
828.24M
47 days until earnings call
Interact to see
Advertisement

ITRM vs KOD

Header iconITRM vs KOD Comparison
Open Charts ITRM vs KODBanner chart's image
Iterum Therapeutics
Price$0.72
Change-$0.02 (-2.70%)
Volume$998
Capitalization33.18M
Kodiak Sciences
Price$15.89
Change+$0.21 (+1.34%)
Volume$400
Capitalization828.24M
ITRM vs KOD Comparison Chart in %
Loading...
ITRM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KOD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ITRM vs. KOD commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ITRM is a StrongBuy and KOD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (ITRM: $0.74 vs. KOD: $15.68)
Brand notoriety: ITRM and KOD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ITRM: 139% vs. KOD: 411%
Market capitalization -- ITRM: $33.18M vs. KOD: $828.24M
ITRM [@Biotechnology] is valued at $33.18M. KOD’s [@Biotechnology] market capitalization is $828.24M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ITRM’s FA Score shows that 1 FA rating(s) are green whileKOD’s FA Score has 0 green FA rating(s).

  • ITRM’s FA Score: 1 green, 4 red.
  • KOD’s FA Score: 0 green, 5 red.
According to our system of comparison, both ITRM and KOD are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ITRM’s TA Score shows that 6 TA indicator(s) are bullish while KOD’s TA Score has 4 bullish TA indicator(s).

  • ITRM’s TA Score: 6 bullish, 2 bearish.
  • KOD’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ITRM is a better buy in the short-term than KOD.

Price Growth

ITRM (@Biotechnology) experienced а +9.33% price change this week, while KOD (@Biotechnology) price change was +59.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.17%. For the same industry, the average monthly price growth was +9.43%, and the average quarterly price growth was +55.19%.

Reported Earning Dates

ITRM is expected to report earnings on Nov 07, 2025.

KOD is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+4.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KOD($828M) has a higher market cap than ITRM($33.2M). KOD YTD gains are higher at: 57.588 vs. ITRM (-58.023). ITRM has higher annual earnings (EBITDA): -20.51M vs. KOD (-170.11M). KOD has more cash in the bank: 104M vs. ITRM (13M). ITRM has less debt than KOD: ITRM (32.6M) vs KOD (65.2M). ITRM (0) and KOD (0) have equivalent revenues.
ITRMKODITRM / KOD
Capitalization33.2M828M4%
EBITDA-20.51M-170.11M12%
Gain YTD-58.02357.588-101%
P/E RatioN/AN/A-
Revenue00-
Total Cash13M104M13%
Total Debt32.6M65.2M50%
FUNDAMENTALS RATINGS
ITRM vs KOD: Fundamental Ratings
ITRM
KOD
OUTLOOK RATING
1..100
685
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
62
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9999
PRICE GROWTH RATING
1..100
6434
P/E GROWTH RATING
1..100
2100
SEASONALITY SCORE
1..100
509

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KOD's Valuation (62) in the Biotechnology industry is in the same range as ITRM (86). This means that KOD’s stock grew similarly to ITRM’s over the last 12 months.

KOD's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ITRM (100). This means that KOD’s stock grew similarly to ITRM’s over the last 12 months.

KOD's SMR Rating (99) in the Biotechnology industry is in the same range as ITRM (99). This means that KOD’s stock grew similarly to ITRM’s over the last 12 months.

KOD's Price Growth Rating (34) in the Biotechnology industry is in the same range as ITRM (64). This means that KOD’s stock grew similarly to ITRM’s over the last 12 months.

ITRM's P/E Growth Rating (2) in the Biotechnology industry is significantly better than the same rating for KOD (100). This means that ITRM’s stock grew significantly faster than KOD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ITRMKOD
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
76%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 2 days ago
86%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 10 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
ITRM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KOD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VSCAX25.71N/A
N/A
Invesco Small Cap Value A
EGORX20.70N/A
N/A
Allspring Large Cap Core R6
FNDMX13.66N/A
N/A
Fidelity Series Sust Non-US Dev Mrkt Fd
DIFGX12.45-0.05
-0.40%
MFS Diversified Income R4
NWHOX31.35-0.19
-0.60%
Nationwide Bailard Tech & Sci A

ITRM and

Correlation & Price change

A.I.dvisor indicates that over the last year, ITRM has been loosely correlated with GLUE. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ITRM jumps, then GLUE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ITRM
1D Price
Change %
ITRM100%
-4.74%
GLUE - ITRM
40%
Loosely correlated
-1.06%
ACRS - ITRM
34%
Loosely correlated
N/A
TARA - ITRM
32%
Poorly correlated
+5.15%
IBRX - ITRM
27%
Poorly correlated
-1.60%
KOD - ITRM
26%
Poorly correlated
+1.23%
More

KOD and

Correlation & Price change

A.I.dvisor indicates that over the last year, KOD has been loosely correlated with XNCR. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if KOD jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KOD
1D Price
Change %
KOD100%
+1.23%
XNCR - KOD
47%
Loosely correlated
-1.34%
MBX - KOD
45%
Loosely correlated
-13.78%
MGNX - KOD
45%
Loosely correlated
-4.07%
MGX - KOD
41%
Loosely correlated
+10.05%
CRBU - KOD
41%
Loosely correlated
-9.39%
More